Last reviewed · How we verify
NCT07338643
The Auxiliary Effect of Artificial Intelligence in the Detection of Precancerous Lesions in Proximal Colon Cancer
trial testing AI group in Abdominal Pain in 1,200 participants. Not yet recruiting.
1 August 2028
Quick facts
| Lead sponsor | Limian Er |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 1,200 |
| Start date | 26 February 2026 |
| Primary completion | 1 August 2028 |
| Estimated completion | 1 August 2028 |
| Sites | 1 location across China |
Drugs / interventions tested
- AI group
- Serial group
- Standard colonoscopy group
Conditions studied
- Abdominal Pain — all drugs for Abdominal Pain →
- Black Stools — all drugs for Black Stools →
- Constipation — all drugs for Constipation →
- Diarrhea — all drugs for Diarrhea →
Sponsor
Limian Er
Who can join
Eligibility, any sex, with Abdominal Pain or Black Stools. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators conducted a multicenter randomized controlled trial to explore the adjuvant effect of artificial intelligence in the detection of precancerous lesions in the proximal colon.This is a prospective, multicenter, single-blind, parallel randomized controlled trial.During the colonoscopy retraction process, the investigators aimed to compare the detection rates of proximal colon adenomas with and without the assistance of an AI(Artificial Intelligence) diagnostic device.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07338643
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Abdominal Pain
Currently open trials in the same condition.
- NCT06381921 — Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain · NA · recruiting
- NCT06268717 — GI Alpha-Gal Study · NA · recruiting
- NCT05730491 — Online Social Learning Program for Parents With Irritable Bowel Syndrome: Raising Resilient Children · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07338643 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Limian Er
- Last refreshed: 14 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07338643.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing